ETFSverige
Hem » Featured, Headline

Introducing the first Saudi Arabia ETF in Europe

25 juli 2018 Inga kommentarer

Introducing the first Saudi Arabia ETF in EuropeIntroducing the first Saudi Arabia ETF in Europe

Saudi Arabia is in the early stages of a huge social and economic transformation, and you can now gain exposure to the growth opportunities through our new fund. This is the first ETF in Europe that provides access to the Middle East’s largest economy. Introducing the first Saudi Arabia ETF in Europe.

Find out:

• What’s driving the growth in Saudi Arabia
• Why we think it’s worth considering investing in Saudi Arabia
• About the index and our Saudi Arabia ETF

Product description

The Invesco MSCI Saudi Arabia UCITS ETF aims to provide the performance of the MSCI Saudi Arabia 20/35 Capped Index, after the impact of fees.

The MSCI Saudi Arabia 20/35 Capped Index captures the large and mid-cap securities of the Saudi Arabia market. The weight of the largest group entity in the index is constrained to 35% and the weights of all other entities are constrained to a maximum of 20%. The index covers approximately 85% of the free float-adjusted market capitalization in Saudi Arabia.

Find out more

Investment risks

Investors should note that the price of your investment may go down as well as up. As a result, you may not get back the amount of capital you invest.

As this is an emerging markets ETF, investors should be prepared to accept a higher degree of risk than for an ETF investing in the securities of issuers in other more established economies or developed countries, as difficulties in dealing, settlement and custody could arise.

The Fund is exposed to the risk of bankruptcy, or any other type of default of the counterparty related to any trading transaction entered into by the Fund.

In order to reach its investment objective, the Fund enters into swap agreements which provide the performance of the Reference Index, and may imply a range of risks which could lead to an adjustment or even the early termination of the swap agreement.

On-exchange liquidity may be limited due insufficient demand, Reference Index suspension, a decision by one of the relevant stock exchanges, or a breach by the market maker of respective stock exchange requirements and guidelines. This may result in share prices that differ significantly from the NAV.

Important information

By accepting this document, you consent to communicating with us in English, unless you inform us otherwise.

This email contains information that is for discussion purposes only, and is intended only for professional investors pursuant to Directive 2004/39/EC (MIFID) Annex II Section in Austria, Belgium, Finland, France, Germany, Italy, Luxembourg, the Netherlands, Norway, Sweden and the UK, Qualified Clients in Israel, and Qualified Investors in Switzerland. Without limitation, this e-mail does not constitute an offer or a recommendation to enter into any transaction. When making an investment decision, you should rely solely on the final documentation and any prospectus relating to the transaction and not this summary. Investment strategies involve numerous risks. Any calculations and charts set out herein are indicative only, make certain assumptions and no guarantee is given that future performance or results will reflect the information herein. Investors should consult their own business, tax, legal and accounting advisors with respect to this proposed transaction and they should refrain from entering into a transaction unless they have fully understood the associated risks and have independently determined that the transaction is appropriate for them. In no way should we be deemed to be holding out as financial advisers or fiduciaries of the recipient hereof.

UCITS ETF’s units / shares purchased on the secondary market cannot usually be sold directly back to UCITS ETF. Investors must buy and sell units / shares on a secondary market with the assistance of an intermediary (e.g. a stockbroker) and may incur fees for doing so. In addition, investors may pay more than the current net asset value when buying units / shares and may receive less than the current net asset value when selling them.

The offering documents and financial reports for the products are available at etf.invesco.com.

German investors may obtain the offering documents free of charge in paper or electronic form from the issuer or from the German information and paying agent (Marcard, Stein & Co AG, Ballindamm 36, 20095 Hamburg, Germany).

In Israel, the contents of this document are restricted to Qualified Clients (pursuant to the First Schedule to the Israeli Regulation of Investment Advice, Investment Marketing and Investment Portfolio Management Law, 1995) only and are not intended for retail or private investors who are not Qualified Clients.

The representative and paying agent for the sub-funds of Invesco Markets plc, Invesco Markets II plc, and PIMCO Fixed Income Source ETFs plc in Switzerland is BNP Paribas Securities Services, Paris, succursale de Zurich, Selnaustrasse 16, 8002 Zurich, Switzerland. The offering documents, articles of incorporation and annual and semi-annual reports may be obtained free of charge from the representative in Switzerland. The ETFs are domiciled in Ireland.

The publication of the supplement in Italy does not imply any judgment by CONSOB on an investment in a product. The list of products listed in Italy, and the offering documents for and the supplement of each ETF are available: (i) at etf.invesco.com (along with the audited annual report and the unaudited half-year reports); and (ii) on the website of the Italian Stock Exchange borsaitaliana.it.

All investment decisions must be based only on information contained in the prospectus, the KIID/KID, the supplement and in the most recent audited annual report or unaudited semi-annual report. Investors should read the specific risks of any product they plan to invest in, which are noted in the prospectus, the KIID and the supplement. Past performance does not guarantee similar future performance. For details on fees and other charges, please consult the prospectus, the KIID and the supplement of each product.

Kommentarer är avstängda.